APA
Oneyama M., Sakamoto N., Oue N., Kimura Y., Hiroshima Y., Hashimoto I., Hara K., Maezawa Y., Kano K., Aoyama T., Fujikawa H., Yamada T., Tamagawa H., Yamamoto N., Ogata T., Cho H., Ito H., Yukawa N., Shiozawa M., Yoshikawa T., Morinaga S., Rino Y., Masuda M., Miyagi Y., Yasui W. & Oshima T. (20191213). Clinical Significance of KIAA1199 as a Novel Target for Gastric Cancer Drug Therapy. : Anticancer research.
Chicago
Oneyama Masataka, Sakamoto Naoya, Oue Naohide, Kimura Yayoi, Hiroshima Yukihiko, Hashimoto Itaru, Hara Kentaro, Maezawa Yukio, Kano Kazuki, Aoyama Toru, Fujikawa Hirohito, Yamada Takanobu, Tamagawa Hiroshi, Yamamoto Naoto, Ogata Takashi, Cho Haruhiko, Ito Hiroyuki, Yukawa Norio, Shiozawa Manabu, Yoshikawa Takaki, Morinaga Soichiro, Rino Yasushi, Masuda Munetaka, Miyagi Yohei, Yasui Wataru and Oshima Takashi. 20191213. Clinical Significance of KIAA1199 as a Novel Target for Gastric Cancer Drug Therapy. : Anticancer research.
Harvard
Oneyama M., Sakamoto N., Oue N., Kimura Y., Hiroshima Y., Hashimoto I., Hara K., Maezawa Y., Kano K., Aoyama T., Fujikawa H., Yamada T., Tamagawa H., Yamamoto N., Ogata T., Cho H., Ito H., Yukawa N., Shiozawa M., Yoshikawa T., Morinaga S., Rino Y., Masuda M., Miyagi Y., Yasui W. and Oshima T. (20191213). Clinical Significance of KIAA1199 as a Novel Target for Gastric Cancer Drug Therapy. : Anticancer research.
MLA
Oneyama Masataka, Sakamoto Naoya, Oue Naohide, Kimura Yayoi, Hiroshima Yukihiko, Hashimoto Itaru, Hara Kentaro, Maezawa Yukio, Kano Kazuki, Aoyama Toru, Fujikawa Hirohito, Yamada Takanobu, Tamagawa Hiroshi, Yamamoto Naoto, Ogata Takashi, Cho Haruhiko, Ito Hiroyuki, Yukawa Norio, Shiozawa Manabu, Yoshikawa Takaki, Morinaga Soichiro, Rino Yasushi, Masuda Munetaka, Miyagi Yohei, Yasui Wataru and Oshima Takashi. Clinical Significance of KIAA1199 as a Novel Target for Gastric Cancer Drug Therapy. : Anticancer research. 20191213.